European Union - English - EMA (European Medicines Agency)

ammtek - glibenclamide - diabetes mellitus - drugs used in diabetes - amglidia is indicated for the treatment of neonatal diabetes mellitus, for use in newborns, infants and children.sulphonylureas like amglidia have been shown to be effective in patients with mutations in the genes coding for the β-cell atp-sensitive potassium channel and chromosome 6q24-related transient neonatal diabetes mellitus.

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - ciprofloxacin lactate - solution for infusion - 2 milligram(s)/millilitre - fluoroquinolones; ciprofloxacin

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - cyclosporin a -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - carbamazepine -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - carbamazepine -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - carbamazepine -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - carbamazepine -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - cyclosporin a -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - cyclosporin a -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - ciclosporin -